Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Leukemia Retrieve available abstracts of 58 articles: HTML format Text format

Single Articles

March 2010
1. HOCKLEY SL , Morilla A, Else M, Dearden C, et al
   Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
2. SINGH RR , Kim JE, Davuluri Y, Drakos E, et al
   Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. ABDOU AM , Gao X, Cozen W, Cerhan JR, et al
   Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. CHANUDET E , Huang Y, Ichimura K, Dong G, et al
   A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.
   Leukemia. 2010;24:488-9.
   PubMed     Text format     Related articles   
   
   
   January 2010
5. GU TL , Cherry J, Tucker M, Wu J, et al
   Identification of activated Tnk1 kinase in Hodgkin's lymphoma.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. BELARDO G , Piva R, Santoro MG
   Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.
   Leukemia. 2010;24:187-96.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
7. CHANUDET E , Huang Y, Ichimura K, Dong G, et al
   A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.
   Leukemia. 2009.
   PubMed     Text format     Related articles   
   
   
   September 2009
8. WILCOX RA , Sun DX, Novak A, Dogan A, et al
   Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines.
   Leukemia. 2009.
   PubMed     Text format     Related articles   
   
   
   
9. DRAKOS E , Atsaves V, Schlette E, Li J, et al
   The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53.
   Leukemia. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
10. ECKERLE S , Brune V, Doring C, Tiacci E, et al
    Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
11. FARFSING A , Engel F, Seiffert M, Hartmann E, et al
    Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. O'RIAIN C , O'Shea DM, Yang Y, Le Dieu R, et al
    Array-based DNA methylation profiling in follicular lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. FERRANDO AA
    Genomic technologies in leukemia and lymphoma: a review series.
    Leukemia. 2009;23:1207.
    PubMed     Text format     Related articles   
    
    
    
14. KILLMANN N
    Introduction to the genomics spotlight.
    Leukemia. 2009;23:1208.
    PubMed     Text format     Related articles   
    
    
    
15. TAKESHITA A , Yamakage N, Shinjo K, Ono T, et al
    CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.
    Leukemia. 2009;23:1329-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. BASSO K
    Toward a systems biology approach to investigate cellular networks in normal and malignant B cells.
    Leukemia. 2009;23:1219-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
17. GASPERINI P , Tosato G
    Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SCHWINDT H , Vater I, Kreuz M, Montesinos-Rongen M, et al
    Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GELEBART P , Zak Z, Anand M, Dien-Bard J, et al
    Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. IQBAL J , Kucuk C, Deleeuw RJ, Srivastava G, et al
    Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
    Leukemia. 2009;23:1139-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
21. KANELLIS G , Roncador G, Arribas A, Mollejo M, et al
    Identification of MNDA as a new marker for nodal marginal zone lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BAUS D , Nonnenmacher F, Jankowski S, Doring C, et al
    STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. RENOUF B , Hollville E, Pujals A, Tetaud C, et al
    Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. COPPO P , Gouilleux-Gruart V, Huang Y, Bouhlal H, et al
    STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. CARBONNELLE-PUSCIAN A , Copie-Bergman C, Baia M, Martin-Garcia N, et al
    The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.
    Leukemia. 2009;23:952-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
26. ROSATI A , Di Salle E, Luberto L, Quinto I, et al
    Identification of a Btk-BAG3 complex induced by oxidative stress.
    Leukemia. 2009;23:823-4.
    PubMed     Text format     Related articles   
    
    
    March 2009
27. ZHANG QL , Wang L, Zhang YW, Jiang XX, et al
    The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. KNECHT H , Sawan B, Lichtensztejn D, Lemieux B, et al
    The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells.
    Leukemia. 2009;23:565-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. FELDMAN AL , Law M, Remstein ED, Macon WR, et al
    Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
    Leukemia. 2009;23:574-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. STRUSKI S , Gervais C, Helias C, Herbrecht R, et al
    Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
    Leukemia. 2009;23:617-9.
    PubMed     Text format     Related articles   
    
    
    February 2009
31. WOYACH JA , Lin TS, Lucas MS, Heerema N, et al
    A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. DRAKOS E , Atsaves V, Li J, Leventaki V, et al
    Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. WANG M , Sun L, Qian J, Han X, et al
    Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. CHEUNG MC , Bailey D, Pennell N, Imrie KR, et al
    In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
35. FARINA L , Bruno B, Patriarca F, Spina F, et al
    The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SANDLUND JT , Pui CH, Zhou Y, Behm FG, et al
    Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. MUSSOLIN L , Bonvini P, Ait-Tahar K, Pillon M, et al
    Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.
    Leukemia. 2009;23:400-2.
    PubMed     Text format     Related articles   
    
    
    January 2009
38. ROSSI D , Rasi S, Franceschetti S, Capello D, et al
    Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. PALOMERO T , Ferrando AA
    Genomic tools for dissecting oncogenic transcriptional networks in human leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. NIITSU N , Okamoto M, Miura I, Hirano M, et al
    Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
41. KREJSGAARD T , Gjerdrum LM, Ralfkiaer E, Lauenborg B, et al
    Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome.
    Leukemia. 2008;22:2230-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. SWORDS R , O'Rafferty C, Giles F, Browne P, et al
    Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
    Leukemia. 2008;22:2277-8.
    PubMed     Text format     Related articles   
    
    
    November 2008
43. POIREL HA , Cairo MS, Heerema NA, Swansbury J, et al
    Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. LU P , Yang C, Guasparri I, Harrington W, et al
    Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma.
    Leukemia. 2008.
    PubMed     Text format     Related articles   
    
    
    
45. XHAARD A , Porcher R, Chien JW, de Latour RP, et al
    Impact of comorbidity indexes on non-relapse mortality.
    Leukemia. 2008;22:2062-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
46. BOERMA EG , Siebert R, Kluin PM, Baudis M, et al
    Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. LWIN T , Crespo LA, Wu A, Dessureault S, et al
    Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. WANG SS , Maurer MJ, Morton LM, Habermann TM, et al
    Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Leukemia. 2008.
    PubMed     Text format     Related articles   
    
    
    
49. KOZAKO T , Yoshimitsu M, Fujiwara H, Masamoto I, et al
    PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. OTZ T , Grosse-Hovest L, Hofmann M, Rammensee HG, et al
    A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. CHRISTOPOULOS P , Follo M, Fisch P, Veelken H, et al
    The peripheral helper T-cell repertoire in untreated indolent B-cell lymphomas: evidence for antigen-driven lymphomagenesis.
    Leukemia. 2008;22:1952-4.
    PubMed     Text format     Related articles   
    
    
    September 2008
52. BUSKE C , Hoster E, Dreyling M, Eimermacher H, et al
    The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Gr
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. BENTINK S , Wessendorf S, Schwaenen C, Rosolowski M, et al
    Pathway activation patterns in diffuse large B-cell lymphomas.
    Leukemia. 2008;22:1746-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
54. KLAPPER W , Stoecklein H, Zeynalova S, Ott G, et al
    Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. KLIER M , Anastasov N, Hermann A, Meindl T, et al
    Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Leukemia. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. PARRENS M , Gachard N, Petit B, Marfak A, et al
    Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories.
    Leukemia. 2008;22:1621-4.
    PubMed     Text format     Related articles   
    
    
    July 2008
57. PEREZ-GALAN P , Roue G, Lopez-Guerra M, Nguyen M, et al
    BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Leukemia. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. LAWRIE CH , Saunders NJ, Soneji S, Palazzo S, et al
    MicroRNA expression in lymphocyte development and malignancy.
    Leukemia. 2008;22:1440-6.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: